IMU imugene limited

1.35%

37.5¢

Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer, page-178

First 178 Last

Share
Profile

Follow
GabeyBabe

343 Posts.

127

16/11/21

22:40

Post #: 57624819
Share

Originally posted by Jase99: ↑

"When asked what success in Phase 2 would mean, Lesley said: "If there are early signs of response, it will move right into registration. As you can tell by the investment they've made it could easily be ran by both companies or maybe their company might take it over".
BANG! There it is. A potential buy-out of Herr-Vax. At least that's the way I read it."

I just watched the Proactive Investors video and it seemed to me the comment was in relation to the study, not a buyout of HER-Vaxx. The benefit of their company taking over the trial is that they would pay for it instead of Imugene. Remember, Imugene is very promiscuous and will be running combo trials with other companies and aren't looking to settle down with a single partner. "This is one of hopefully many."

No worries. In the Proactive Investors video LC described the design of the trial pretty much how I thought it would go. It's a very exciting approach for them to look at what's going on in the samples after treatment. Hopefully all that they get to look at is dead tumours killed by HER-Vaxx.

Expand

Hi Jase99

I am just wondering what your background is if I may ask re biotech space? Do you have medical background? You seem to be really on the ball re the details and interpreting the process?

Thanks

GB

IMU Price at posting: 59.5¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

SYR

Syrah jumps +19% as graphite tariff threat spurs optimism down under

STN

Saturn brings up seventh straight Apollo Hill upgrade on 'impressive' 300-hole drill run

ASX Market Open: Can we squeeze one more record reset into Week 29? | July 18

SER

Strategic Energy extends its QLD copper-gold frontier with Diamantina acquisition

BDM

Burgundy plunges -20% after turning to layoffs to navigate record-low diamond prices

AII

A new NASDAQ listing for a key player in the global critical minerals space

DRO

History repeats for DroneShield investors but carnage so far subdued

PSC

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

HotCopper Highlights: Trigg; Droneshield; Lumos & more

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

First 178 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 37.5¢		Change 0.005(1.35%)		Mkt cap ! $82.39M

Open	High	Low	Value	Volume
37.0¢	37.5¢	36.0¢	$342.2K	938.4K

Buyers (Bids)

No.	Vol.	Price($)
1	488	37.0¢

Sellers (Offers)

Price($)	Vol.	No.
37.5¢	12566	2

View Market Depth

No.	Vol.	Price($)
1	488	0.370
5	64338	0.365
10	266455	0.360
8	164035	0.355
16	165231	0.350

Price($)	Vol.	No.
0.375	12566	2
0.380	21000	2
0.385	18651	4
0.390	17530	3
0.395	222522	6

Last trade - 16.10pm 18/07/2025 (20 minute delay)

IMU (ASX) Chart

Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer, page-178

Syrah jumps +19% as graphite tariff threat spurs optimism down under

Saturn brings up seventh straight Apollo Hill upgrade on 'impressive' 300-hole drill run

ASX Market Open: Can we squeeze one more record reset into Week 29? | July 18

Strategic Energy extends its QLD copper-gold frontier with Diamantina acquisition

Burgundy plunges -20% after turning to layoffs to navigate record-low diamond prices

A new NASDAQ listing for a key player in the global critical minerals space

History repeats for DroneShield investors but carnage so far subdued

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

HotCopper Highlights: Trigg; Droneshield; Lumos & more

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer, page-178

Top Stories

Syrah jumps +19% as graphite tariff threat spurs optimism down under

Saturn brings up seventh straight Apollo Hill upgrade on 'impressive' 300-hole drill run

ASX Market Open: Can we squeeze one more record reset into Week 29? | July 18

Strategic Energy extends its QLD copper-gold frontier with Diamantina acquisition

Burgundy plunges -20% after turning to layoffs to navigate record-low diamond prices

A new NASDAQ listing for a key player in the global critical minerals space

History repeats for DroneShield investors but carnage so far subdued

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

HotCopper Highlights: Trigg; Droneshield; Lumos & more

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News